Pricing
Navigating IRA Price Negotiations: What Manufacturers Need to Know
A comprehensive guide to preparing for Medicare drug price negotiations under the Inflation Reduction Act.
Expert perspectives on market access, pricing strategy, HEOR, and competitive intelligence.
Artificial intelligence is revolutionizing how pharmaceutical companies approach market access strategy. From predictive pricing models to real-time competitive monitoring, discover how AI is reshaping the industry landscape.
A comprehensive guide to preparing for Medicare drug price negotiations under the Inflation Reduction Act.
How to structure and present health economics evidence that resonates with payers and HTA bodies.
Strategic considerations for sequencing market launches to maximize value across regions.
Key indicators to track for anticipating competitive threats in your therapeutic area.
Analysis of evolving international reference pricing policies and their impact on launch strategies.
Leveraging real-world data to strengthen market access arguments and demonstrate value post-launch.